Headaches in the forehead area, pressure around the eyes, and nasal congestion – is it sinusitis or migraine? Sometimes, distinguishing between these conditions is more difficult than it seems. A new clinical study of the Ayurvedic formulation Cephagraine provides interesting findings for people experiencing both types of headaches.
When a Headache Is Not What It Seems
Imagine the following situation: you wake up with heaviness in your forehead, discomfort around your eyes, and a headache that intensifies throughout the day. Your first thought is probably sinusitis.
But could it actually be a migraine?
Yes. Although they have different underlying causes, migraine and sinusitis-related headaches can sometimes present with similar symptoms.
Migraine is not always just a throbbing pain on one side of the head. In some people, it is accompanied by watery eyes, nasal congestion, or a feeling of pressure in the face. This is why some headaches perceived as sinus headaches may actually be migraine attacks.
Identifying the underlying cause is important because the approaches to managing these conditions are different.
How Can You Tell Migraine Apart from a Sinus Headache?
Certain symptoms may provide useful clues, although they are not sufficient on their own to establish a diagnosis.
Migraine is often associated with:
-
Moderate to severe headaches, sometimes throbbing.
-
Pain that worsens with physical activity.
-
Nausea or vomiting.
-
Increased sensitivity to light and sound.
-
In some people, nasal congestion, watery eyes, or pressure around the eyes.
Acute sinusitis is more commonly associated with:
-
Nasal congestion and nasal discharge.
-
Reduced sense of smell.
-
Facial pain or pressure.
-
Symptoms developing during or after an upper respiratory tract infection.
-
Sometimes, fever.
If headaches recur, especially when accompanied by nausea or sensitivity to light, it is advisable to discuss the possibility of migraine with a healthcare professional.
What Does the New Clinical Study of Cephagraine Show?
In January 2026, a clinical study focusing on the Ayurvedic formulation Cephagraine for migraine and sinusitis-related headaches was published in the Journal of Ayurveda and Integrated Medical Sciences.
The study included 300 participants aged 18 to 60, divided into two groups:
-
150 participants diagnosed with migraine.
-
150 participants experiencing sinusitis-related headaches.
Over a period of 15 days, all participants received Cephagraine tablets in combination with Cephagraine nasal drops.
The researchers monitored pain intensity, headache frequency, and the impact of headaches on everyday life.
Results in Participants with Migraine
Among participants with migraine, average pain intensity, measured using a ten-point Visual Analogue Scale (VAS), changed as follows:
-
At baseline: 7.8 points.
-
On day eight: 4.2 points.
-
On day fifteen: 2.6 points.
This represents an approximately 67% reduction in the average reported pain intensity over the observation period.
The researchers also reported an improvement in the MIDAS score, which assesses how much migraine interferes with daily activities. The average score decreased from 18.4 to 8.2 points – an improvement of 55.4%.
Another interesting finding was that 82% of participants with migraine reported marked improvement by the end of the study.
What Were the Results for Sinusitis-Related Headaches?
Positive changes were also reported among participants experiencing sinusitis-related headaches.
Average pain intensity decreased from 7.5 to 2.9 points over 15 days.
Scores on the SNOT-22 questionnaire, which evaluates nasal and sinus symptoms and their impact on quality of life, improved by 52.8%.
78% of participants reported marked improvement based on their own assessment.
What Do These Results Mean?
The findings are promising, but it is important to interpret them in the context of the study design.
The trial was open-label, without a placebo control group, and participants were followed for only 15 days. In addition, Cephagraine tablets and nasal drops were used together, making it impossible to determine the independent contribution of the tablets.
The study was funded by Charak Pharma, which is another relevant consideration when evaluating the findings.
Therefore, the publication provides a basis for further interest in the formulation and additional research, but it does not establish that Cephagraine alone treats migraine or sinusitis.
What Is Cephagraine?
Cephagraine is a multi-ingredient Ayurvedic formulation developed by Charak Pharma, combining botanical ingredients intended to support comfort in the head and upper respiratory tract.
Some of the ingredients in the tablets include:
-
Tulsi (Ocimum sanctum) – supports normal respiratory function and has antioxidant properties. It contains active compounds investigated for their anti-inflammatory potential.
-
Ginger (Zingiber officinale) – helps relieve nausea, which frequently accompanies migraine attacks. It contains gingerols with investigated anti-inflammatory properties.
-
Long Pepper (Piper longum) – supports respiratory comfort and the clearance of respiratory secretions. Its constituent piperine may enhance the absorption of certain plant-derived compounds.
-
Bhringaraj (Eclipta alba) – contains antioxidant compounds that help protect cells against oxidative stress. Some of its active constituents are being studied for their anti-inflammatory activity.
-
Sitopaladi Churna – a traditional herbal combination used to support respiratory comfort, the clearance of secretions, and soothing of an irritated throat.
Combining different plants in a single formulation is a characteristic Ayurvedic approach, in which ingredients are selected to complement one another's functions.
Can Cephagraine Be Part of Migraine Care?
Migraine is a neurological disorder, and its management depends on the frequency, severity, and characteristics of the attacks.
Alongside treatment prescribed by a healthcare professional, regular sleep, adequate hydration, balanced eating habits, and identifying individual triggers can play an important role.
Cephagraine is a food supplement that may be discussed with a healthcare professional as a complementary approach. It does not replace prescribed medication and should not be used as a reason to delay diagnosis or treatment.
Conclusion: Promising Results and the Need for Further Research
Migraine and sinusitis-related headaches can be more similar than we might expect. Distinguishing between them is the first step toward appropriate care.
The published clinical study of Cephagraine reported significant improvements in symptoms among participants with migraine and sinusitis-related headaches following 15 days of combined treatment with tablets and nasal drops.
The findings are interesting and encourage further investigation of the Ayurvedic formulation, including longer-term, randomized, placebo-controlled studies.
Explore Cephagraine by Charak Pharma, 100 Tablets at Himalaya.bg.
Scientific Reference
Mote D., Mali S., Maurya M., Bhandari S. Effect of Cephagraine Tablets and Nasal Drops in Patients with Migraine and Sinusitis-Related Headache: An Open-Label Clinical Trial. Journal of Ayurveda and Integrated Medical Sciences, 10(12), 43–49. Published January 16, 2026.
DOI: https://doi.org/10.21760/jaims.10.12.7
Important: This article is for informational purposes only and does not replace professional medical advice. Sudden, unusually severe headaches, neurological symptoms, or significant changes in headache patterns require immediate medical evaluation.
Post comment